Literature DB >> 19440811

Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication.

Katsunori Iijima1, Tomoyuki Koike, Yasuhiko Abe, Nobuyuki Ara, Kaname Uno, Akira Imatani, Shuichi Ohara, Tooru Shimosegawa.   

Abstract

PURPOSE: The measurement of serum pepsinogens is clinically useful to represent gastric acid secretion. Since both serum pepsinogens and gastric acid secretion are considerably altered by H. pylori eradication, the correlation between these two parameters could be different prior to and after eradication. In this study, we investigated the correlation between the two parameters prior to and after eradication.
METHODS: One hundred eighteen H. pylori-positive patients with peptic ulcers or chronic gastritis were enrolled in this retrospective analysis. In all participants both the measurement of serum pepsinogens and the determination of gastric acid secretion were performed prior to and at 1 month after successful eradication. In 85 subjects, the same assessments were repeated at 7 months. Correlations between serum pepsinogens and gastric acid secretion were assessed using linear regression analysis.
RESULTS: The pepsinogen I/II ratio (r = 0.56) was a better indicator of gastric acid secretion in H. pylori-infected subjects than pepsinogen I itself (r = 0.31). Eradication of H. pylori altered the association, causing pepsinogen I (r = 0.55) to become a better indicator of gastric acid secretion compared with the pepsinogen I/II ratio (r = 0.40) at 1 month after eradication, followed by similar tendencies at 7 months.
CONCLUSION: Using different serum biomarkers (pepsinogen I/II ratio prior to eradication or pepsinogen I after eradication), the measurement of serum pepsinogens is useful for predicting the individual gastric acid secretion level not only in H. pylori-infected subjects, but also in subjects with histories of eradication of the infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19440811     DOI: 10.1007/s00535-009-0066-2

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  49 in total

1.  Verification of decreased basal and stimulated serum pepsinogen-I levels is a useful non-invasive method for determining the success of eradication therapy for Helicobacter pylori.

Authors:  J P Gisbert; D Boixeda; T Vila; L de Rafael; C Redondo; R Cantón; C Martín de Argila
Journal:  Scand J Gastroenterol       Date:  1996-02       Impact factor: 2.423

2.  Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence.

Authors:  I M Samloff; W M Liebman
Journal:  Gastroenterology       Date:  1973-07       Impact factor: 22.682

3.  Serum pepsinogens as a screening test of extensive chronic gastritis.

Authors:  K Miki; M Ichinose; A Shimizu; S C Huang; H Oka; C Furihata; T Matsushima; K Takahashi
Journal:  Gastroenterol Jpn       Date:  1987-04

4.  Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects.

Authors:  D Vaira; N Vakil; M Rugge; L Gatta; C Ricci; M Menegatti; G Leandro; J Holton; V M Russo; M Miglioli
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

5.  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease.

Authors:  F Cremonini; S Di Caro; S Delgado-Aros; A Sepulveda; G Gasbarrini; A Gasbarrini; M Camilleri
Journal:  Aliment Pharmacol Ther       Date:  2003-08-01       Impact factor: 8.171

6.  Influence of Helicobacter pylori, sex, and age on serum gastrin and pepsinogen concentrations in subjects without symptoms and patients with duodenal ulcers.

Authors:  S Mossi; B Meyer-Wyss; E L Renner; H S Merki; G Gamboni; C Beglinger
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

7.  The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan.

Authors:  Yasuhiko Abe; Shuichi Ohara; Tomoyuki Koike; Hitoshi Sekine; Katsunori Iijima; Masashi Kawamura; Akira Imatani; Katsuaki Kato; Tooru Shimosegawa
Journal:  Am J Gastroenterol       Date:  2004-07       Impact factor: 10.864

8.  Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease.

Authors:  E M el-Omar; I D Penman; J E Ardill; R S Chittajallu; C Howie; K E McColl
Journal:  Gastroenterology       Date:  1995-09       Impact factor: 22.682

Review 9.  Alteration of histological gastritis after cure of Helicobacter pylori infection.

Authors:  M Hojo; H Miwa; T Ohkusa; R Ohkura; A Kurosawa; N Sato
Journal:  Aliment Pharmacol Ther       Date:  2002-11       Impact factor: 8.171

10.  Comparison of gastric acid secretion rates and serum pepsinogen I and II concentrations in Occidental and Oriental duodenal ulcer patients.

Authors:  M Feldman; C T Richardson; S K Lam; I M Samloff
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

View more
  4 in total

1.  Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis.

Authors:  Dariush Nasrollahzadeh; Karim Aghcheli; Masoud Sotoudeh; Ramin Shakeri; E Christina Persson; Farhad Islami; Farin Kamangar; Christian C Abnet; Paolo Boffetta; Lars Engstrand; Sanford M Dawsey; Reza Malekzadeh; Weimin Ye
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

2.  The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China.

Authors:  Xiao-mei Zhang; Jia-xin Li; Gui-ying Zhang; Xin-hua Li; Huan Gu
Journal:  BMC Gastroenterol       Date:  2014-01-03       Impact factor: 3.067

3.  Acidic bile salts induces mucosal barrier dysfunction through let-7a reduction during gastric carcinogenesis after Helicobacter pylori eradication.

Authors:  Yasushi Takahashi; Kaname Uno; Katsunori Iijima; Yasuhiko Abe; Tomoyuki Koike; Naoki Asano; Kiyotaka Asanuma; Tooru Shimosegawa
Journal:  Oncotarget       Date:  2018-04-06

4.  Efficacy of acotiamide on postprandial distress syndrome and epigastric pain syndrome depending on the estimated gastric acid secretion level.

Authors:  Toshiaki Suzuki; Reina Ohba; Ei Kataoka; Yui Kudo; Akira Zeniya; Daisuke Segawa; Keisuke Oikawa; Masaru Odashima; Taiji Saga; Tomoyuki Kuramitsu; Hideaki Sasahara; Kazuo Yoneyama; Takashi Tomita; Yosuke Shimodaira; Katsunori Iijima
Journal:  J Neurogastroenterol Motil       Date:  2022-01-30       Impact factor: 4.924

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.